Aussie opportunity 'too good to pass up': Greenfern
Medicinal cannabis co inks $900,000 distributor deal.
Mon, 10 Jan 2022
NZX-listed medical cannabis firm Greenfern has reached a deal with an Australian distributor to significantly boost sales across the Tasman.
Greenfern said today it had reached an agreement with Cannvalate to boost the marketing of its GFI Pharma products in Australia. The deal sees Greenfern
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
